体内CAR-Tin vivo CAR-T

体内重编程T细胞

每条都摘自下方编号的来源原文;只写事实,不写预测或建议。

技术简介

  • Starna正在开发直接在患者体内重编程细胞的RNA药物。1
    Starna is developing RNA medicines that are designed to reprogram cells inside the body — or “in vivo” — while also branching into fields beyond oncology.

来源

  1. biopharmadive.com · Pfizer leaps into ‘in vivo’ CAR-T with latest China deal | BioPharma Dive · 2026-11-18